EBV LMP2A Antikörper
EBV LMP2A
Reaktivität: Epstein-Barr Virus (EBV)
IHC (p), WB
Wirt: Ratte
Monoclonal
15F9
unconjugated
(2 Referenzen)-
- Target Alle EBV LMP2A Produkte
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
- Reaktivität
- Epstein-Barr Virus (EBV)
-
Wirt
- Ratte
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser EBV LMP2A Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Immunogen
- Bacterial TrpE-LMP2A fusion protein
- Klon
- 15F9
- Isotyp
- IgG1
-
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1.0 mg/mL
-
-
: "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
: "Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22." in: Neoplasia (New York, N.Y.), Vol. 11, Issue 11, pp. 1174-84, (2009) (PubMed).
-
: "Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation." in: Journal of neuropathology and experimental neurology, Vol. 69, Issue 7, pp. 677-93, (2010) (PubMed).
-
- Target
- EBV LMP2A (Epstein-Barr Virus Latent Membrane Protein 2A (EBV LMP2A))
- Andere Bezeichnung
- EPSTEIN-BARR VIRUS LMP2A (EBV LMP2A Produkte)
- Synonyme
- - antikoerper, LMP2A antikoerper
- Substanzklasse
- Viral Protein
- Hintergrund
- Synonyms: EBV
-
Sie sind hier:
